在脑肌瘤症中对帕金森症的系统性审查
Jennifer Hanson1, Penelope E Bonnen1
1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Neurology international
|August 27, 2025
概括
脑肌松症 (CTX) 可能是由于神经退行导致的早期帕金森症. 多巴胺类药物有效治疗CTX患者的帕金森症状.
科学领域:
- 神经学
- 代谢疾病
- 遗传学
背景情况:
- 脑肌松症 (CTX) 是一种罕见的遗传代谢疾病,由CYP27A1变体引起.
- 临床表现包括认知缺陷,,神经病变,白内障,肌瘤,有时还有帕金森症.
研究的目的:
- 在患有脑肌瘤 (CTX) 患者中鉴定帕金森症.
- 提高有关CTX相关帕金森症的认识和数据.
主要方法:
- 按照PRISMA指南进行系统文献审查.
- 在72名CTX和帕金森症患者的临床症状,成像和治疗反应分析.
主要成果:
- 在CTX中帕金森症通常在42岁左右开始.
- 可能是多巴胺系统的神经退化, 通过成像证明.
- 脑小叶MRI异常 (88%) 是CTX的特征,有助于差异诊断.
结论:
- CTX可能表现为对利沃多巴反应的帕金森症.
- 在非典型帕金森症的差分诊断中应考虑CTX.
更多相关视频
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
7.5K
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
1.7K
相关概念视频
Parkinson's Disease: Overview
702
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
702
Parkinson's Disease: Treatment
376
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
376
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
Neural Regulation
39.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.9K
